• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chest. In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)

Giuseppe

Emeritus
[Source: Chest, full text: (LINK). Abstract, edited.]

In Vivo Platelet Activation in Critically Ill Patients With Primary 2009 Influenza A(H1N1)


Matthew T. Rondina, MD, BreAnna Brewster, Colin K. Grissom, MD, FCCP, Guy A. Zimmerman, MD, Diana H. Kastendieck, BA, Estelle S. Harris, MD, FCCP and Andrew S. Weyrich, PhD

Author Affiliations: From the Division of General Internal Medicine (Dr Rondina) and the Division of Pulmonary and Critical Care Medicine (Drs Grissom, Zimmerman, Harris, and Weyrich), Department of Internal Medicine, and the Program in Molecular Medicine (Drs Rondina and Weyrich and Mss Brewster and Kastendieck), University of Utah School of Medicine, Salt Lake City; and the Intermountain Medical Center (Dr Grissom), Division of Critical Care, Murray, UT.

Correspondence to: Matthew T. Rondina, MD, University of Utah, Department of Internal Medicine, 50 N Medical Dr, Room 4B120, Salt Lake City, UT 84132; e-mail: matthew.rondina@hsc.utah.edu



Abstract

Background: Changes in platelet reactivity during 2009 influenza A(H1N1) (A[H1N1]) have not been characterized.

Methods: We prospectively examined platelet activation and cytokine responses in patients with A(H1N1) (n = 20), matched patients with bacterial pneumonia (n = 15), and nonhospitalized, healthy control subjects (n = 10).

Results: Platelet-monocyte aggregation was higher in patients with A(H1N1) (21.4% ? 4.7%) compared with patients with pneumonia (10.9% ? 3.7%) and control subjects (8.1% ? 4.5%, P < .05). Similarly, PAC-1 (antibody that binds to the active conformation of integrin α<SUB>IIb</SUB>β<SUB>3</SUB>) binding to platelets is increased in patients with A(H1N1) (9.5% ? 4.7%) compared with patients with pneumonia (1.0% ? 0.7%) and healthy subjects (0.61% ? 0.15%, P < .10). PAC-1 binding was twofold higher in patients with A(H1N1) with shock vs those without shock. IL-6 levels were elevated in patients with A(H1N1), indicating systemic inflammation consistent with activation of circulating platelets.

Conclusions: These findings, derived from a small but documented cohort of patients, demonstrate that platelet activation responses during A(H1N1) are enhanced?exceeding responses in patients with bacterial pneumonia?and provide new evidence that platelets may contribute to inflammatory responses during A(H1N1).



Footnotes

Reproduction of this article is prohibited without written permission from the American College of Chest Physicians. See online for more details.

Funding/Support: This work was supported by the National Institutes of Health [Grants HL091754, HL066277, and K23HL092161] and the National Center for Research Resources public health service [Grant ULI-RRO25764].

Abbreviations: A(H1N1), 2009 influenza A(H1N1) - ALI, acute lung injury - APACHE, Acute Physiology and Chronic Health Evaluation - FITC, fluorescein isothiocyanate - PAC-1, antibody that binds to the active conformation of integrin α<SUB>IIb</SUB>β<SUB>3</SUB> ? PMA, platelet-monocyte aggregate ? SSC, side scatter - TRAP, thrombin-receptor activating peptide - TNF-α, tumor necrosis factor-α

Received November 9, 2011. Accepted February 4, 2012. ? 2012 American College of Chest Physicians

-
------
 
Back
Top Bottom